ONTOLOGY REPORT - ANNOTATIONS
| Term: | abnormal immune system morphology |
|
| Accession: | MP:0000685
|
browse the term
|
| Definition: | any structural anomaly in the organs or cells associated with the development and formation of lymphocytes |
| Synonyms: | exact_synonym: | immune system abnormalities; immune system dysplasia; lymphoid system abnormalities; lymphopoietic system abnormalities |
|
|
abnormal CD8-positive T cell morphology
|
| Q |
Cdexp1 |
CD45RC expression in CD8 T cells QTL 1 |
|
|
IAGP |
9 |
1 |
26,311,568 |
RGD:1302824 |
RGD |
| Q |
Cdexp2 |
CD45RC expression in CD8 T cells QTL 2 |
|
|
IAGP |
20 |
3,660,638 |
10,410,227 |
RGD:1302824 |
RGD |
abnormal leukocyte cell number
|
| Q |
Cm6 |
Cardiac mass QTL 6 |
|
|
QTM |
7 |
47,145,774 |
107,950,815 |
RGD:727992 |
RGD |
| Q |
Wbc1 |
White blood cell count QTL 1 |
|
|
QTM |
5 |
89,261,341 |
147,065,912 |
RGD:727992 |
RGD |
abnormal lymphopoiesis
|
| S |
WIN/RhwRrrc |
|
|
|
TAS |
|
|
|
RGD:2292495 |
RGD |
abnormal macrophage morphology
|
| G |
Gfi1 |
growth factor independent 1 transcription repressor |
|
|
IEA |
14 |
2,597,303 |
2,606,681 |
RGD:704404 |
RGD |
abnormal mononuclear cell differentiation
|
| S |
BN |
BN |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
abnormal osteoclast differentiation
|
| S |
LEW-tl |
|
|
|
IED |
|
|
|
RGD:619693 |
RGD |
abnormal T cell differentiation
|
| S |
WKAH.LEC-Ptprkthid/Tj |
|
|
|
TAS |
1 |
17,328,563 |
17,752,200 |
RGD:1302502 |
RGD |
athymia
|
| G |
Foxn1 |
forkhead box N1 |
|
|
IAGP |
10 |
64,243,323 |
64,256,847 |
RGD:1300512 |
RGD |
| S |
F344.Cg-Foxn1rnu/Kyo |
|
|
|
TAS |
10 |
64,243,323 |
64,256,847 |
RGD:1302502 |
RGD |
decreased leukocyte cell number
|
| Q |
Wbc3 |
White blood cell count QTL 3 |
|
Induced |
IED |
5 |
112,840,801 |
157,840,801 |
RGD:2316974 |
RGD |
| Q |
Wbc4 |
White blood cell count QTL 4 |
|
Induced |
IED |
7 |
1 |
36,741,943 |
RGD:2316974 |
RGD |
| Q |
Wbc5 |
White blood cell count QTL 5 |
|
Induced |
IED |
8 |
10,116,155 |
55,116,155 |
RGD:2316974 |
RGD |
| S |
BBDP.WF-(D8Rat59-D8Sunn1467)/Sunn |
|
|
|
IED |
8 |
112,242,639 |
128,970,675 |
RGD:1624306 |
RGD |
decreased lymphocyte cell number
|
| S |
BB/N |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BBDP/Hri |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BBDP/Rhw |
|
|
|
QTM |
|
|
|
RGD:61480 |
RGD |
| S |
BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
TAS |
4 |
75,808,584 |
77,809,321 |
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Arb11-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Got33-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Got59-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat102-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/1Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/2Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/3Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat153-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat153-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat253-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat253-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat26-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBDR.F344-(D4Rat27-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw |
|
|
|
IED |
|
|
|
RGD:2306526 |
RGD |
| S |
BBZ |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BDIX |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
LEW.Cg-Foxn1rnu/NRrrc |
|
|
|
TAS |
|
|
|
RGD:2292495 |
RGD |
decreased mast cell number
|
| G |
Hdc |
histidine decarboxylase |
|
|
IEA |
3 |
114,119,316 |
114,138,107 |
RGD:704404 |
RGD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
|
IAGP |
14 |
34,906,043 |
34,984,819 |
RGD:5133424 |
RGD |
decreased neutrophil cell number
|
| G |
Gfi1 |
growth factor independent 1 transcription repressor |
|
|
IEA |
14 |
2,597,303 |
2,606,681 |
RGD:704404 |
RGD |
decreased Peyer's patch number
|
| S |
LEW.Cg-Foxn1rnu/NRrrc |
|
|
|
TAS |
|
|
|
RGD:2292495 |
RGD |
decreased thymus weight
|
| S |
SS-Rag1em2Mcwi |
|
|
|
IED |
|
|
|
RGD:7207429 |
RGD |
enlarged mesenteric lymph nodes
|
| S |
BN.MES-Cyba/Sna |
|
|
|
IED |
|
|
|
RGD:5134976 |
RGD |
enlarged spleen
|
| G |
Hbb |
hemoglobin, beta |
|
|
IEA |
1 |
161,618,782 |
161,620,193 |
RGD:704404 |
RGD |
enlarged thymus
|
| Q |
Thym3 |
Thymus enlargement QTL 3 |
|
|
QTM |
1 |
141,471,946 |
186,471,946 |
RGD:70859 |
RGD |
| Q |
Thym4 |
Thymus enlargement QTL 4 |
|
|
QTM |
1 |
202,906,624 |
247,906,624 |
RGD:70859 |
RGD |
increased activated T cell number
|
| Q |
Ean2 |
Experimental allergic neuritis QTL 2 |
|
|
IED |
4 |
82,700,691 |
96,313,512 |
RGD:2306769 |
RGD |
| Q |
Ean4 |
Experimental allergic neuritis QTL 4 |
|
|
IED |
10 |
87,849,516 |
98,392,508 |
RGD:2306769 |
RGD |
| Q |
Ean5 |
Experimental allergic neuritis QTL 5 |
|
|
IED |
10 |
76,043,832 |
98,392,296 |
RGD:2306769 |
RGD |
increased double-negative T cell number
|
| Q |
Neudeg2 |
Neurodegradation QTL 2 |
|
|
IAGP |
5 |
25,602,274 |
45,822,846 |
RGD:1358788 |
RGD |
| Q |
Neuinf1 |
Neuroinflammation QTL 1 |
|
|
IAGP |
5 |
161,449,395 |
173,096,209 |
RGD:1358788 |
RGD |
increased eosinophil cell number
|
| Q |
Leukc1 |
Leukocyte quantity QTL 1 |
|
|
IED |
19 |
12,235,101 |
57,235,101 |
RGD:5135221 |
RGD |
| Q |
Leukc2 |
Leukocyte quantity QTL 2 |
|
|
IED |
2 |
121,545,310 |
155,102,371 |
RGD:5135221 |
RGD |
| Q |
Leukc3 |
Leukocyte quantity QTL 3 |
|
|
IED |
1 |
223,729,174 |
229,876,997 |
RGD:5135222 |
RGD |
| S |
BN.MES-Cyba/Sna |
|
|
|
IED |
|
|
|
RGD:5134976 |
RGD |
| S |
MES/Slc |
Matsumoto Eosinophilia Shinshu |
|
|
IED |
|
|
|
RGD:5134988 |
RGD |
increased leukocyte cell number
|
| Q |
Wbc1 |
White blood cell count QTL 1 |
|
|
IAGP |
5 |
89,261,341 |
147,065,912 |
RGD:727992 |
RGD |
| Q |
Wbc2 |
White blood cell count QTL 2 |
|
|
IAGP |
12 |
25,271,823 |
32,988,661 |
RGD:70849 |
RGD |
| S |
BDIX |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
increased T cell number
|
| Q |
Iddm1 |
Insulin dependent diabetes mellitus QTL 1 |
|
|
IED |
|
|
|
RGD:61075 |
RGD |
increased T cell proliferation
|
| Q |
Ean2 |
Experimental allergic neuritis QTL 2 |
|
|
IED |
4 |
82,700,691 |
96,313,512 |
RGD:2306769 |
RGD |
| Q |
Ean4 |
Experimental allergic neuritis QTL 4 |
|
|
IED |
10 |
87,849,516 |
98,392,508 |
RGD:2306769 |
RGD |
| Q |
Ean5 |
Experimental allergic neuritis QTL 5 |
|
|
IED |
10 |
76,043,832 |
98,392,296 |
RGD:2306769 |
RGD |
small thymus
|
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
|
IAGP |
7 |
113,043,365 |
113,049,779 |
RGD:727991 |
RGD |
| Q |
Tsu1 |
Thymus enlargement suppressive QTL 1 |
|
|
QTM |
3 |
47,722,800 |
115,996,144 |
RGD:634729 |
RGD |
thymus atrophy
|
| Q |
Esta4 |
Estrogen-induced thymic atrophy QTL 4 |
|
Induced |
IED |
3 |
44,551,252 |
149,496,698 |
RGD:2292503 |
RGD |
| S |
ACI.COP-(D10Mgh8-D10Rat4)/Shul |
|
|
Induced |
IED |
10 |
53,781,126 |
107,033,716 |
RGD:2292503 |
RGD |
| S |
ACI.COP-(D3Mgh16-D3Rat119)/Shul |
|
|
Induced |
IED |
3 |
6,373,335 |
52,643,538 |
RGD:2292503 |
RGD |
| S |
ACI.COP-(D3Rat130-D3Rat114)/Shul |
|
|
Induced |
IED |
3 |
44,551,252 |
149,496,698 |
RGD:2292503 |
RGD |
| S |
ACI.COP-(D6Rat80-D6Rat146)/Shul |
|
|
Induced |
IED |
6 |
16,302,145 |
16,302,283 |
RGD:2292503 |
RGD |
thymus hyperplasia
|
| Q |
Thym1 |
Thymus enlargement QTL 1 |
|
|
QTM |
1 |
141,471,946 |
186,471,946 |
RGD:70859 |
RGD |
| Q |
Thym2 |
Thymus enlargement QTL 2 |
|
|
QTM |
13 |
47,699,094 |
88,282,502 |
RGD:70859 |
RGD |
| S |
BUF/Mna |
|
|
|
QTM |
|
|
|
RGD:619599 |
RGD |
| S |
COP |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
W/Nhg |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
WAB |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
Term paths to the root
|